Lista de obras - Mark T Ledwidge - Dominio Público Uruguay

A Central Role for Monocyte-Platelet Interactions in Heart Failure

artículo científico publicado en 2015

A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program

artículo científico publicado en 2016

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

artículo científico publicado en 2019

Are beta2-agonists responsible for increased mortality in heart failure?

artículo científico

Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population?

artículo científico publicado en 2014

Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management.

artículo científico publicado en 2013

Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

artículo científico publicado en 2013

B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.

artículo científico publicado en 2017

B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.

artículo científico publicado en 2011

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? ⬇️

artículo científico publicado el 30 de junio de 2011

Can individualized weight monitoring using the HeartPhone algorithm improve sensitivity for clinical deterioration of heart failure?

artículo científico publicado en 2012

Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population.

artículo científico publicado en 2010

Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?

artículo científico publicado en 2005

Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study

artículo científico publicado en 2015

Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain

artículo científico publicado en 2007

Developing a disease management program for the improvement of heart failure outcomes: the do's and the don'ts

scientific article published on 08 April 2019

Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and management

artículo científico publicado en 2017

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

artículo científico publicado en 2009

Diagnosis of new onset heart failure in the community: the importance of a shared-care approach and judicious use of BNP.

artículo científico publicado en 2008

Diagnostics and therapeutic interventions in myocardial interstitial disease, a previously neglected pathology ⬇️

artículo científico publicado el 29 de mayo de 2012

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

artículo científico publicado en 2007

Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin ⬇️

artículo científico publicado el 1 de junio de 2012

Disease management programs for heart failure: not just for the 'sick' heart failure population

artículo científico publicado en 2006

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2007

Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk.

artículo científico publicado en 2006

Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-convertin

artículo científico publicado en 2001

Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.

artículo científico publicado en 2015

Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis

scientific article published on 18 November 2014

Extracellular matrix sub-types and mechanical stretch impact human cardiac fibroblast responses to transforming growth factor beta

artículo científico publicado en 2014

Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype.

artículo científico publicado en 2011

Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community - A mixed-methods evaluation.

artículo científico publicado en 2017

Heart Failure in Sub-Saharan Africa

article

Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs.

artículo científico publicado en 2005

Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics

artículo científico publicado en 2015

Heart failure management programs: can we afford to ignore the inpatient phase of care?

artículo científico publicado en 2003

Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care

scientific article published on 01 June 2002

Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.

artículo científico publicado en 2013

Importance of risk factor management in diabetic patients and reduction in Stage B heart failure

artículo científico publicado en 2014

Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.

artículo científico publicado en 2007

In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?

artículo científico publicado en 2012

Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure.

artículo científico publicado en 2016

Intrauterine insemination-No more Mr. N.I.C.E. guy?

artículo científico publicado en 2017

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.

artículo científico publicado en 2016

Life expectancy for community-based patients with heart failure from time of diagnosis.

artículo científico publicado en 2014

Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets

scientific article published on 10 November 2011

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

artículo científico publicado en 2015

Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.

artículo científico publicado en 2012

Multidisciplinary care of heart failure: what have we learned and where can we improve?

artículo científico publicado en 2003

Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

artículo científico publicado en 2008

Natriuretic Peptide-based Screening and Prevention of Heart Failure

artículo científico publicado en 2017

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial

artículo científico

Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure

scientific article published on 15 October 2019

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

artículo científico publicado en 2009

Need and evolution of need for device therapy in a community heart failure population.

artículo científico publicado en 2008

Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactions

artículo científico publicado en 2014

Nondipping Nocturnal Blood Pressure Predicts Sleep Apnea in Patients With Hypertension

artículo científico publicado en 2019

Novel Iron-Whey Protein Microspheres Protect Gut Epithelial Cells from Iron-Related Oxidative Stress and Damage and Improve Iron Absorption in Fasting Adults.

artículo científico publicado en 2018

Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.

artículo científico publicado en 2008

Physicochemical characterization of diclofenac N-(2-hydroxyethyl)pyrrolidine: anhydrate and dihydrate crystalline forms

scientific article published on 01 January 1996

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

artículo científico publicado en 2011

Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history study

scientific article published on 01 January 2006

Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.

artículo científico

Proteomic Analysis of Coronary Sinus Serum Reveals Leucine-Rich α2-Glycoprotein as a Novel Biomarker of Ventricular Dysfunction and Heart Failure ⬇️

artículo científico publicado el 31 de enero de 2011

Quality of life predicts outcome in a heart failure disease management program.

artículo científico publicado en 2008

Role of Monitoring Devices in Preventing Heart Failure Admissions.

artículo científico

Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.

artículo científico publicado en 2012

Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease.

artículo científico publicado en 2015

Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions.

artículo científico publicado en 2004

Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?

artículo científico publicado en 2003

Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes

artículo científico publicado en 2019

The Heart Failure Virtual Consultation - a powerful tool for the delivery of specialist care and the democratization of knowledge in the community

scientific article published on 28 December 2018

The St Vincent's potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care.

artículo científico

The prehospital patient pathway and experience of care with acute heart failure: a comparison of two health care systems

artículo científico publicado en 2020

Lista de obras de Mark T Ledwidge

A Central Role for Monocyte-Platelet Interactions in Heart Failure

A comparison of HFrEF vs HFpEF's clinical workload and cost in the first year following hospitalization and enrollment in a disease management program

A systematic review of clinical prediction rules for the diagnosis of chronic heart failure

Are beta2-agonists responsible for increased mortality in heart failure?

Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population?

Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management.

Attenuation of monocyte chemotaxis--a novel anti-inflammatory mechanism of action for the cardio-protective hormone B-type natriuretic peptide.

B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in Hypertension.

B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent's Screening TO Prevent Heart Failure) study.

Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure? ⬇️

Can individualized weight monitoring using the HeartPhone algorithm improve sensitivity for clinical deterioration of heart failure?

Clinical and psychological impact of prophylactic implantable cardioverter-defibrillators in a community heart failure population.

Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?

Cost-effectiveness of natriuretic peptide-based screening and collaborative care: a report from the STOP-HF (St Vincent's Screening TO Prevent Heart Failure) study

Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain

Developing a disease management program for the improvement of heart failure outcomes: the do's and the don'ts

Diabetes and complications of the heart in Sub-Saharan Africa: An urgent need for improved awareness, diagnostics and management

Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover.

Diagnosis of new onset heart failure in the community: the importance of a shared-care approach and judicious use of BNP.

Diagnostics and therapeutic interventions in myocardial interstitial disease, a previously neglected pathology ⬇️

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction.

Differential inhibition of tumour cell‐induced platelet aggregation by the nicotinate aspirin prodrug (ST0702) and aspirin ⬇️

Disease management programs for heart failure: not just for the 'sick' heart failure population

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

Elevated BNP with normal systolic function in asymptomatic individuals at-risk for heart failure: a marker of diastolic dysfunction and clinical risk.

Elimination of early rehospitalization in a randomized, controlled trial of multidisciplinary care in a high-risk, elderly heart failure population: the potential contributions of specialist care, clinical stability and optimal angiotensin-convertin

Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis.

Exaggerated inflammation and monocytosis associate with diastolic dysfunction in heart failure with preserved ejection fraction: evidence of M2 macrophage activation in disease pathogenesis

Extracellular matrix sub-types and mechanical stretch impact human cardiac fibroblast responses to transforming growth factor beta

Getting to the heart of cardiac remodeling; how collagen subtypes may contribute to phenotype.

Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community - A mixed-methods evaluation.

Heart Failure in Sub-Saharan Africa

Heart failure care in a hospital unit: a comparison of standard 3-month and extended 6-month programs.

Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics

Heart failure management programs: can we afford to ignore the inpatient phase of care?

Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care

Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.

Importance of risk factor management in diabetic patients and reduction in Stage B heart failure

Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patients.

In vivo impact of prodrug isosorbide-5-nicotinate-2-aspirinate on lipids and prostaglandin D2: is this a new immediate-release therapeutic option for niacin?

Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure.

Intrauterine insemination-No more Mr. N.I.C.E. guy?

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up.

Life expectancy for community-based patients with heart failure from time of diagnosis.

Mechanisms of aggregation inhibition by aspirin and nitrate-aspirin prodrugs in human platelets

MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure

Modest elevation in BNP in asymptomatic hypertensive patients reflects sub-clinical cardiac remodeling, inflammation and extracellular matrix changes.

Multidisciplinary care of heart failure: what have we learned and where can we improve?

Multiple neurohumoral modulating agents in systolic dysfunction heart failure: are we lowering blood pressure too much?

Natriuretic Peptide-based Screening and Prevention of Heart Failure

Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial

Natriuretic peptide-guided treatment for the prevention of cardiovascular events in patients without heart failure

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

Need and evolution of need for device therapy in a community heart failure population.

Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance--NO and MMP-9 interactions

Nondipping Nocturnal Blood Pressure Predicts Sleep Apnea in Patients With Hypertension

Novel Iron-Whey Protein Microspheres Protect Gut Epithelial Cells from Iron-Related Oxidative Stress and Damage and Improve Iron Absorption in Fasting Adults.

Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalisations for acute decompensated heart failure.

Physicochemical characterization of diclofenac N-(2-hydroxyethyl)pyrrolidine: anhydrate and dihydrate crystalline forms

Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

Progression of preserved systolic function heart failure to systolic dysfunction -- a natural history study

Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.

Proteomic Analysis of Coronary Sinus Serum Reveals Leucine-Rich α2-Glycoprotein as a Novel Biomarker of Ventricular Dysfunction and Heart Failure ⬇️

Quality of life predicts outcome in a heart failure disease management program.

Role of Monitoring Devices in Preventing Heart Failure Admissions.

Screening to prevent heart failure (STOP-HF): expanding the focus beyond asymptomatic left ventricular systolic dysfunction.

Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease.

Specialist care of heart failure improves appropriate pharmacotherapy at the expense of greater polypharmacy and drug-interactions.

Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?

Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes

The Heart Failure Virtual Consultation - a powerful tool for the delivery of specialist care and the democratization of knowledge in the community

The St Vincent's potentially inappropriate medicines study: development of a disease-specific consensus list and its evaluation in ambulatory heart failure care.

The prehospital patient pathway and experience of care with acute heart failure: a comparison of two health care systems